New medicine that restricts Organ Transplant Rejection can protect against Alzheimer’s Incidences of the neuro-degenerative disorders less in organ transplant patients. Anti-rejection medication prescribed to organ transplant patients could have the potential to guard them from Alzheimer’s disease, says a new research study. This new finding has observed low incidence of Alzheimer’s disease in those patients who were administered calcineurin inhibitor-based drugs to prevent organ rejection. A recently publishes study on Alzheimer’s disease documented the medical records of 2,600 individuals who underwent organ transplant surgery . It was noted that in comparison to the general population these patients showed lower incidences of Alzheimer’s disease and dementia. The study detailed that only eight out the selected number of patients showed signs of dementia. When this data is compared to the national data on the prevalence of Alzheimer's, it was concluded that the
IndiCure is one of the top medical tourism companies offering quality treatment at best hospitals in India at affordable cost for Weight loss surgery, Cosmetic surgery, Cancer treatment, Knee replacement, Brain surgery and more. To Plan Your Medical Trip to India, Call IndiCure at +1-877-270-2448 (US Toll Free), +91-932-003-6777 (India number). Write to info@indicure.com or Skype@Indicure